Small Animal Imaging (In-Vivo) Market Trends, Top Companies, Share, Growth And Forecast 2033

The new report published by The Business Research Company, titled "Small Animal Imaging (In-Vivo) Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the small animal imaging (in-vivo) market size has grown rapidly in recent years. It will grow from $2.59 billion in 2023 to $2.91 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The small animal imaging (in-vivo) market size is expected to see rapid growth in the next few years. It will grow to $4.55 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

Elevated Healthcare Expenditure Fueling Growth In The Small Animal Imaging (In-Vivo) Market
Growing expenditure in the healthcare sector is expected to propel the growth of the small animal imaging (in vivo) market going forward. Healthcare expenditure refers to the overall cost of health care (including public and private expenditures) as a percentage of GDP. Rising healthcare expenditure and increasing healthcare awareness encourage the concept of self-care management, where PET equipment is used in techniques such as small animal imaging. For instance, in May 2023, the Office for National Statistics, a UK-based statistics authority, reported that healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. UK total healthcare expenditure in 2021 was $367.25 billion (£280.7 billion), and pharmaceutical expenditure was $51.84 billion (£39.6 billion) in 2021. Furthermore, spending on preventive care was $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Therefore, growing expenditure for the healthcare sector is driving the growth of the small animal imaging (in-vivo) market.

Technology Advancements Drive Growth In The Small Animal Imaging (In-Vivo) Market
Technological advancement is a key trend gaining popularity in the small animal imaging (in-vivo) market. Major companies operating in the small animal imaging (in vivo) market are focused on technological advancement to strengthen their position. For instance, in April 2022, PerkinElmer, Inc., a US-based company engaged in business areas such as diagnostics, life science research, and imaging, launched the Vega imaging system, an automated advanced technology ultrasound platform. Automated technology involves the use of two automated transducers, resulting in easy-to-use technology and generating more consistent results to visualize the pathophysiology of the disease.

The small animal imaging (in-vivo) market covered in this report is segmented -

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components
2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics
3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=7303&type=discount

Major companies operating in the small animal imaging (in-vivo) market include Bruker Corporation, PerkinElmer Inc., Miltenyi Biotec GmbH, Aspect Imaging Ltd., Mediso Ltd., Siemens AG, Life Technologies Corporation, Promega Corporation, McKesson Corporation, Integra LifeSciences Holdings Corporation, Smith & Nephew plc, B. Braun Melsungen AG, Paul Hartmann AG, Nitto Denko Corporation, Beiersdorf Aktiengesellschaft, NICHIBAN Co. Ltd., Coloplast A/S, Scapa Group plc, Milliken & Company, Winner Medical Group Inc., Hollister Incorporated, Avcor Health Care Products Inc., Advancis Medical LLC, The ASO Group, Dynarex Corporation, Jiangxi 3L Medical Products Group Co. Ltd., Berthold Technologies GmbH and Co. KG, Spectral Instruments Imaging LLC, Agilent Technologies Inc., Bioscan Inc., Gamma Medica-Ideas Inc., Genovis AB, LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc.

Contents of the report:
1. Executive Summary
2. Small Animal Imaging (In-Vivo) Market Report Structure
3. Small Animal Imaging (In-Vivo) Market Trends And Strategies
4. Small Animal Imaging (In-Vivo) Market - Macro Economic Scenario
5. Small Animal Imaging (In-Vivo) Market Size And Growth
…..
27. Small Animal Imaging (In-Vivo) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.